Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;33(4):506-511.
doi: 10.1097/ACO.0000000000000877.

Remimazolam for anaesthesia or sedation

J Robert Sneyd  1 , Ann E Rigby-Jones  2
Affiliations
Review

Remimazolam for anaesthesia or sedation

J Robert Sneyd et al. Curr Opin Anaesthesiol. 2020 Aug.

Abstract

Purpose of review: Anaesthesia and sedation are ubiquitous in contemporary medical practice. Developments in anaesthetic pharmacology are targeted on reducing physiological disturbance whilst maintaining or improving titrateability, recovery profile and patient experience. Remimazolam is a new short-acting benzodiazepine in the final stages of clinical development.

Recent findings: Clinical experience with remimazolam comprises volunteer studies and a limited number of clinical investigations. In addition, laboratory investigations explore the implications of its 'soft drug' pharmacology.

Summary: Remimazolam provides effective procedural sedation with superior success rates and recovery profile when compared to midazolam. Comparisons with propofol are required. Preliminary studies suggest potential for using remimazolam as the hypnotic component of general anaesthesia. Definitive studies are awaited. As a benzodiazepine, remimazolam could be evaluated as an anticonvulsant and for intensive care sedation.

PubMed Disclaimer

References

    1. Egan TD. Is anesthesiology going soft? Trends in fragile pharmacology. Anesthesiology 2009; 111:229–230.
    1. Zhou Y, Hu P, Jiang J. Metabolite characterization of a novel sedative drug, remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry. J Pharm Biomed Anal 2017; 137:78–83.
    1. Freyer N, Knospel F, Damm G, et al. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Devel Ther 2019; 13:1033–1047.
    1. Dundee JW. Intravenous anaesthesia and the need for new agents. Postgrad Med J 1985; 61: (Suppl 3): 3–6.
    1. Eisenried A, Schüttler J, Lerch M, et al. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers. Part II. Pharmacodynamics of electroencephalogram effects. Anesthesiology 2020; 132:652–666.